Results 181 to 190 of about 38,142 (215)
Some of the next articles are maybe not open access.
American Journal of Critical Care, 1997
Malignant hyperthermia is a pharmacogenetic disease of skeletal muscle characterized by hypermetabolism that occurs on exposure to a triggering agent or agents. The most common agents are halogenated inhalational anesthetics and succinylcholine, a depolarizing muscle relaxant.
A D, Miranda +3 more
openaire +4 more sources
Malignant hyperthermia is a pharmacogenetic disease of skeletal muscle characterized by hypermetabolism that occurs on exposure to a triggering agent or agents. The most common agents are halogenated inhalational anesthetics and succinylcholine, a depolarizing muscle relaxant.
A D, Miranda +3 more
openaire +4 more sources
Annals of Emergency Medicine, 1987
Malignant hyperthermia is a hereditary trait characterized by hypercatabolic reactions induced by anesthetic drugs, or physical or emotional stress. Patients must be treated quickly and efficiently in order to prevent irreversible organ damage and death.
J L, Tomarken, B A, Britt
openaire +2 more sources
Malignant hyperthermia is a hereditary trait characterized by hypercatabolic reactions induced by anesthetic drugs, or physical or emotional stress. Patients must be treated quickly and efficiently in order to prevent irreversible organ damage and death.
J L, Tomarken, B A, Britt
openaire +2 more sources
The Journal of the American Dental Association, 1979
A case has been presented that illustrates successful managment of a patient with suspected malignant hyperthermia. The causes of this disorder are uncertain. If screening procedures identify a patient as susceptible to this disorder, careful planning in the preoperative stage is indicated.
openaire +4 more sources
A case has been presented that illustrates successful managment of a patient with suspected malignant hyperthermia. The causes of this disorder are uncertain. If screening procedures identify a patient as susceptible to this disorder, careful planning in the preoperative stage is indicated.
openaire +4 more sources
Malignant Hyperthermia Susceptibility and Related Diseases
Anesthesiology, 2018 This review identifies disease states associated with malignant hyperthermia susceptibility based on genotypic and phenotypic findings, and a framework is established for clinicians to identify a potentially malignant hyperthermia–susceptible patient.
, James J Dowling
exaly +2 more sources
Best Practice & Research Clinical Anaesthesiology, 2003
Malignant hyperthermia (MH) is an uncommon, life-threatening, acute pharmacogenetic disorder of the skeletal muscle cell. It manifests in susceptible individuals as a hypermetabolic response on exposure to halogenated volatile anaesthetics and depolarizing muscle relaxants.
Syed Z, Ali +2 more
openaire +4 more sources
Malignant hyperthermia (MH) is an uncommon, life-threatening, acute pharmacogenetic disorder of the skeletal muscle cell. It manifests in susceptible individuals as a hypermetabolic response on exposure to halogenated volatile anaesthetics and depolarizing muscle relaxants.
Syed Z, Ali +2 more
openaire +4 more sources
Oral Surgery, Oral Medicine, Oral Pathology, 1986
The increasing use of intravenous and inhalation sedation in the dental office has the potential of increasing the incidence of malignant hyperthermia (MH) in susceptible subjects. The object of this article is to present two cases of MH and to discuss its pathophysiology, its clinical picture, and its management in the light of the current literature.
R Y, Cantin, A, Poole, J F, Ryan
+8 more sources
The increasing use of intravenous and inhalation sedation in the dental office has the potential of increasing the incidence of malignant hyperthermia (MH) in susceptible subjects. The object of this article is to present two cases of MH and to discuss its pathophysiology, its clinical picture, and its management in the light of the current literature.
R Y, Cantin, A, Poole, J F, Ryan
+8 more sources
Acta Pathologica Japonica, 1982
A report is made of a 65‐year‐old male who died of a malignant hyperthermia of 42°C. Symptoms included muscle rigidity at the termination of operation for neck‐clipping of an aneurysm of the anterior communicating artery. Latent myopathy was observed in skeletal muscle, and a bleeding focus was present in the left anterior region of the hypothalamus ...
M, Ohmori +3 more
openaire +2 more sources
A report is made of a 65‐year‐old male who died of a malignant hyperthermia of 42°C. Symptoms included muscle rigidity at the termination of operation for neck‐clipping of an aneurysm of the anterior communicating artery. Latent myopathy was observed in skeletal muscle, and a bleeding focus was present in the left anterior region of the hypothalamus ...
M, Ohmori +3 more
openaire +2 more sources
Pediatric Clinics of North America, 1994
Major advances have occurred in the management of MH since this disorder was first described. Despite the initially high mortality, deaths secondary to MH have dramatically decreased over the past 15 years, which is due in large part to the discovery of efficacious therapy.
S J, Kaus, M A, Rockoff
openaire +2 more sources
Major advances have occurred in the management of MH since this disorder was first described. Despite the initially high mortality, deaths secondary to MH have dramatically decreased over the past 15 years, which is due in large part to the discovery of efficacious therapy.
S J, Kaus, M A, Rockoff
openaire +2 more sources
Malignant Hyperthermia or Not Malignant Hyperthermia
ICU Director, 2013In an acute event, the diagnosis of malignant hyperthermia (MH) in patients in the ICU can be challenging. Initial presentation may be attributed to a gamut of causes, making the diagnosis complicated. This example is the case of a 46-year-old African American man who was admitted to the Stroke Service and intubated for respiratory distress.
Alexander F. Bautista +1 more
openaire +1 more source
Nursing Standard, 2006
Malignant hyperthermia, also known as malignant hyperpyrexia, is a pharmacogenetic condition which can develop during general anaesthesia and can be fatal. The author suggests that more awareness of the condition is needed by ward-based nurses who are involved with patients undergoing surgery.
openaire +4 more sources
Malignant hyperthermia, also known as malignant hyperpyrexia, is a pharmacogenetic condition which can develop during general anaesthesia and can be fatal. The author suggests that more awareness of the condition is needed by ward-based nurses who are involved with patients undergoing surgery.
openaire +4 more sources